Skip to content
Stay updated with the latest tech trends, gadget reviews, a…

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Agreement Because of Data Fears

Medical aid illustration
The proposed US funding was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (£272m) over five years due to Washington's insistence on confidential information.

The decision became public after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government spokesperson later clarified that the United States was seeking genetic material for scientific study and commercial gain but was unwilling to share the resulting advantages from future treatments.

"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more talks to find a agreement acceptable to both sides so the nation's critical HIV programme can proceed.

Wider Background

This development follows a comparable situation in Kenya, where a court suspended a related health funding agreement after concerns were filed about the safety of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.

Based on statements, Sixteen nations in Africa have so far signed similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Rejected Agreement

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to provide its genetic material and health information indefinitely, without any corresponding promise of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our people if a future health crisis emerge."

Sovereignty and Global Health

Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks previously established through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.

"This framework is intended to ensure that when a country provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."

The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We are open to further dialogue with our US partners on how subsequent collaboration might be designed in a way that honours the sovereignty and interests of each country."

Medical Community Reaction

A leading public health body said it understood the government's concerns, but recommended that talks should continue since a large portion of the nation's Aids initiatives depended on foreign aid.

"If technical issues exist, such as those involving information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

The halted deal highlights the complex debate between receiving crucial international aid and safeguarding a country's data in an ever more interconnected world.

About the author

Ryan Castro

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and consumer electronics.

UpdateNet360

Type to search articles.